The company's foray into electrolyte manufacturing complements the government's Make in India initiative.

The stock has given 312 per cent return in 3 years!

Vineet Laboratories Ltd experienced a substantial upswing, hitting the upper circuit at Rs. 68.01, driven by an impressive 17.89 times surge in trading volume. The trading floor buzzed with activity as 1,87,011 units changed hands during this dynamic session.

FII stake increase: Foreign Institutional Investors (FIIs) have increased their stake in Lincoln Pharma from 0.63 per cent in September 2022 to 2.59 per cent in September 2023.

Promoter holding increase: The promoter holding in Lincoln Pharma has also increased from 44.09 per cent in September 2022 to 50.53 per cent in September 2023.

Overall, Trident Lifeline Limited's Q1FY24 financial performance demonstrates its strong market position and ability to capitalize on growth opportunities in the pharmaceutical industry.

On Monday, shares of the company surged by 0.56 per cent to trade at Rs 1,041.25.

This drug had estimated annual sales of USD 262 million in the US.

Shares of the company saw a spurt in volume by more than 2.67 times on BSE.

As the season of financial results is on the company has reported numbers; stock surged by 4.25 per cent today. 

The stock has returned 71.50 per cent year to date and in just one year, it has generated multibagger gains of 224.16 per cent.